Table of Contents
International Journal of Proteomics
Volume 2015, Article ID 587250, 10 pages
http://dx.doi.org/10.1155/2015/587250
Research Article

A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma

1Department of Immunotechnology and CREATE Health, Lund University, Medicon Village 406, 223 81 Lund, Sweden
2Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 28029 Madrid, Spain
3Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 28029 Madrid, Spain
4Department of Experimental and Health Sciences, University of Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain
5Hospital del Mar Medical Research Institute (IMIM), CIBERESP, UAB, Dr. Aiguader 88, 08003 Barcelona, Spain

Received 20 May 2015; Accepted 28 September 2015

Academic Editor: Djuro Josic

Copyright © 2015 Anna S. Gerdtsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Christer Wingren, “Antibody-Based Proteomics,” Proteogenomics, vol. 926, pp. 163–179, 2016. View at Publisher · View at Google Scholar
  • Payam Delfani, Linda Dexlin Mellby, Malin Nordström, Andreas Holmér, Mattias Ohlsson, Carl A. K. Borrebaeck, and Christer Wingren, “Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics,” Plos One, vol. 11, no. 7, pp. e0159138, 2016. View at Publisher · View at Google Scholar
  • Anna Sandström Gerdtsson, Christer Wingren, Helena Persson, Payam Delfani, Malin Nordström, He Ren, Xin Wen, Ulrika Ringdahl, Carl A.K. Borrebaeck, and Jihui Hao, “Plasma protein profiling in a stage defined pancreatic cancer cohort – implications for early diagnosis,” Molecular Oncology, 2016. View at Publisher · View at Google Scholar
  • Orla Coleman, Michael Henry, Gerard McVey, Martin Clynes, Michael Moriarty, and Paula Meleady, “Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact,” Expert Review of Proteomics, vol. 13, no. 4, pp. 383–394, 2016. View at Publisher · View at Google Scholar
  • Douglas S Swords, Matthew A Firpo, Courtney L Scaife, and Sean J Mulvihill, “Biomarkers in pancreatic adenocarcinoma: current perspectives.,” OncoTargets and therapy, vol. 9, pp. 7459–7467, 2016. View at Publisher · View at Google Scholar
  • Robert Słotwiński, and Sylwia Małgorzata Słotwińska, “Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.,” Central-European journal of immunology, vol. 41, no. 4, pp. 392–403, 2016. View at Publisher · View at Google Scholar
  • Yi Huang, and Heng Zhu, “Protein Array-based Approaches for Biomarker Discovery in Cancer,” Genomics, Proteomics & Bioinformatics, 2017. View at Publisher · View at Google Scholar
  • Keiji Hanada, Hironobu Amano, and Tomoyuki Abe, “Early diagnosis of pancreatic cancer: Current trends and concerns,” Annals of Gastroenterological Surgery, vol. 1, no. 1, pp. 44–51, 2017. View at Publisher · View at Google Scholar
  • P. Gomez-Rubio, V. Rosato, M. Márquez, C. Bosetti, E. Molina-Montes, M. Rava, J. Piñero, C. W. Michalski, A. Farré, X. Molero, M. Löhr, L. Ilzarbe, J. Perea, W. Greenhalf, M. O’Rorke, A. Tardón, T. Gress, V. M. Barberá, T. Crnogorac-Jurcevic, L. Muñoz-Bellvís, E. Domínguez-Muñoz, A. Gutiérrez-Sacristán, J. Balsells, E. Costello, C. Guillén-Ponce, J. Huang, M. Iglesias, J. Kleeff, B. Kong, J. Mora, L. Murray, D. O’Driscoll, P. Peláez, I. Poves, R. T. Lawlor, A. Carrato, M. Hidalgo, A. Scarpa, L. Sharp, L. I. Furlong, F. X. Real, C. La Vecchia, and N. Malats, “A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk,” Annals of Oncology, vol. 28, no. 7, pp. 1618–1624, 2017. View at Publisher · View at Google Scholar
  • Carl A. K. Borrebaeck, “Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer,” Nature Reviews Cancer, 2017. View at Publisher · View at Google Scholar
  • Julia Mayerle, Holger Kalthoff, Regina Reszka, Beate Kamlage, Erik Peter, Bodo Schniewind, Sandra González Maldonado, Christian Pilarsky, Claus-Dieter Heidecke, Philipp Schatz, Marius Distler, Jonas A Scheiber, Ujjwal M Mahajan, F Ulrich Weiss, Robert Grützmann, and Markus M Lerch, “Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis,” Gut, vol. 67, no. 1, pp. 128–137, 2017. View at Publisher · View at Google Scholar
  • Barbara J. Kenner, Vay Liang W. Go, Suresh T. Chari, Ann E. Goldberg, and Laura J. Rothschild, “Early Detection of Pancreatic Cancer,” Pancreas, vol. 46, no. 10, pp. 1238–1241, 2017. View at Publisher · View at Google Scholar
  • Dagmar Quandt, Tapan Nayak, Michael Kazinski, Charles Massie, Michele Maio, Robert Prins, Björn Wendik, Daniel Enderle, Heinz Zwierzina, Anne Wulf-Goldenberg, Carl Borrebaeck, Diether Lambrechts, James Garrett, Heidi Schwarzenbach, Richard Hockett, Mikkel Noerholm, Hans Dieter Zucht, Hans Hendriks, Barbara Seliger, Arno Amann, Michael Cannarile, and Herbert Oberacher, “Implementing liquid biopsies into clinical decision making for cancer immunotherapy,” Oncotarget, vol. 8, no. 29, pp. 48507–48520, 2017. View at Publisher · View at Google Scholar
  • Fabian Kiessling, “The changing face of cancer diagnosis: From computational image analysis to systems biology,” European Radiology, 2018. View at Publisher · View at Google Scholar
  • Chiara Fania, Raffaele Pezzilli, Gianvico Melzi d’Eril, Cecilia Gelfi, and Alessandra Barassi, “Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma,” Digestive Diseases and Sciences, 2018. View at Publisher · View at Google Scholar
  • Anubhav Srivastava, and Darren John Creek, “Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics,” Proteomics, pp. 1700448, 2018. View at Publisher · View at Google Scholar
  • James L. Abbruzzese, Dana K. Andersen, Carl A.K. Borrebaeck, Suresh T. Chari, Eithne Costello, Zobeida Cruz-Monserrate, Guido Eibl, Edgar G. Engleman, William E. Fisher, Aida Habtezion, Seung K. Kim, Murray Korc, Craig Logsdon, Costas A. Lyssiotis, Stephen J. Pandol, Anil Rustgi, Bruce M. Wolfe, Lei Zheng, and Alvin C. Powers, “The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation,” Pancreas, vol. 47, no. 5, pp. 516–525, 2018. View at Publisher · View at Google Scholar